CD4 and cancer: After adjusting for time-updated exposure to ARVs in a sensitivity analysis, rates of ADCs and infection-related cancers no longer significantly decreased, suggesting that the effect of ART use on CD4 count, at least in part, is the likely explanation for the reduction in the incidence of these cancers.